|
The American Psychopathological Association (APPA), founded in 1910, is devoted to the scientific investigation of disordered human behavior and its biological and psychosocial substrates. Its primary function is to sponsor an annual conference on a specific topic relevant to research in psychopathology. Leading investigators from the U.S. and abroad are invited to give original papers on the topic chosen by the President. This annual conference provides a unique opportunity to learn about, discuss, and debate cutting edge issues in the topic area. It is open to all mental health professionals and trainees, as well as APPA members. Annual MeetingThe annual conference is held in Manhattan beginning the first Thursday of March and ending on the following Saturday at noon. The next meeting, Substance Use, Substance Use Disorders: Changing Concepts, Changing Patterns, will take place March 5-7, 2020 at the Crowne Plaza Times Square in New York. Please check our Registration page for more information and for the downloadable form. Attendees may register early for a significant discount. New for 2020! CME and CE credits will be available for the meeting at no additional charge. Participants at the annual conference include students, mental health scientists and practitioners. Therefore another important APPA function is to provide a forum for high level professional and social contact between established investigators, younger researchers, interested clinicians, and trainees. Special registration rates are available for students attending the meeting. 2020 Meeting ProgramPsychedelics: Risks and Opportunity - APPA Fall 2019 WebinarOur first-ever mid-year meeting was held on November 20, 2019, and focused on the risks and therapeutic opportunities for psychedelics with Deborah Hasin, Professor of Epidemiology (in Psychiatry) at Columbia University, and Matthew Johnson, Director of the Psychedelic Center at Johns Hopkins Department of Psychiatry and Behavioral Sciences. Psychedelics, such as psilocybin, mescaline, and LSD, are a class of drugs capable of inducing mental, visual, and auditory hallucinations, altered sense of time and consciousness, and include possible adverse reactions such as nausea and panic. This online webinar will be made available here for APPA members. MembershipFor over a century, APPA has brought diverse groups of researchers, policy makers and scholars together to an annual meeting where vital issues and developments in psychopathology are presented and discussed. Although the meeting is open to all mental health professionals and researchers, the bulk of those attending belong to the community of APPA members. The members are active basic and clinical researchers whose observations, questions and insights are always valuable. Indeed, a unique feature of the APPA annual meetings is that there is a single series of presentations on a specific theme and there is scheduled discussion that involves members of the audience. More About APPA Membership |